AprilBio Co.,Ltd
- Biotech or pharma, therapeutic R&D
Aprilbio is a biotech company located in Korea. We develop innovative recombinant protein acting antibody-like, with proprietary platform technology SAFA-Albumin binder Fab. Two lead candidates utilizing SAFA have been successfully out-licensed to H.Lundbeck A/S and Evommune Inc, and are currently in clinical stage for patient PoC. Building on the versatility of our SAFA platform, we are expanding our pipeline into multi-specific biologics and antibody-drug conjugates (ADCs). We are actively seeking collaboration partners for our preclinical-stage programs.